课题基金 / 基金详情

HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS

HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
批准号:
2634147
负责人:
Mira Edgerton
金额:
$10.25万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 1999-12-31

项目摘要

项目成果

Mira Edgerton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (lifted from Abstract): Histatins (Hst) are one of the major salivary proteins that appear to have fungicidal activity in the mouth. Oropharyngeal candidiasis (OPC) in HIV-infected individuals may be the result of an alteration in the interactions between Hst and Candida albicans. These researchers have identified a surface protein on Candida, HstBP, that may be the receptor or binding protein for Hst. They suggest that HstBP may be related to efflux pumps such as the ABC transporters or the Major Facilitator superfamily. They hypothesize that OPC may be the result of Candida strains with altered expression of HstBP. They propose to characterize HstBP expression as an underlying mechanism in the development of candidiasis in HIV patients by the following specific aims: 1. Purify HstBP by standard biochemical methods, clone and sequence the HstBP gene. 2. Define the biologic role of HstBP by identifying common structural features, and by assessing the effects of certain physiological mediators on HstBP. 3. Compare HstBP expression in yeasts that are sensitive or resistant to Hst from patients with OPC by determining HstBP molecules/cell using standard binding assays and by levels of mRNA expression using Northern blot analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
海外基金